000724858 000__ 05309cam\a2200529Ii\4500
000724858 001__ 724858
000724858 005__ 20230306140555.0
000724858 006__ m\\\\\o\\d\\\\\\\\
000724858 007__ cr\cn\nnnunnun
000724858 008__ 141215t20142015sz\a\\\\o\\\\\001\0\eng\d
000724858 019__ $$a908086799
000724858 020__ $$a9783319096629$$qelectronic book
000724858 020__ $$a3319096621$$qelectronic book
000724858 020__ $$z9783319096612
000724858 035__ $$aSP(OCoLC)ocn898125753
000724858 035__ $$aSP(OCoLC)898125753$$z(OCoLC)908086799
000724858 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dGW5XE$$dN$T$$dOCLCF$$dIDEBK$$dEBLCP
000724858 049__ $$aISEA
000724858 050_4 $$aRG159
000724858 08204 $$a618.1$$223
000724858 24500 $$aFrontiers in gynecological endocrinology.$$nVolume 2,$$pFrom basic science to clinical application$$h[electronic resource] /$$cBart C.J.M. Fauser, Andrea R. Genazzani, editors.
000724858 24630 $$aFrom basic science to clinical application
000724858 264_1 $$aCham :$$bSpringer,$$c[2014]
000724858 264_4 $$c©2015
000724858 300__ $$a1 online resource (vii, 206 pages) :$$billustrations (some color)
000724858 336__ $$atext$$btxt$$2rdacontent
000724858 337__ $$acomputer$$bc$$2rdamedia
000724858 338__ $$aonline resource$$bcr$$2rdacarrier
000724858 4901_ $$aISGE Series,$$x2197-8735
000724858 500__ $$aIncludes index.
000724858 5050_ $$aPart I: Adolescent Gynecology; 1: Disorders of the Menstrual Cycle During Adolescence; 1.1 Dysfunctional Uterine Bleeding (DUB); 1.2 Amenorrhea; 1.3 Oligomenorrhea; 1.4 Dysmenorrhea; 1.5 Clinical Cases; Conclusion; References; 2: PCOS and Insulin Resistance (IR): From Lifestyle to Insulin Sensitizers; 2.1 Introduction; 2.2 The Impact of Obesity on the Features of PCOS Patients; 2.3 Endocrine Profile of PCOS Patients; 2.4 Lifestyle Modification in PCOS Treatment; 2.5 Use of Insulin Sensitizer Agents and Inositol in PCOS Treatment; References
000724858 5058_ $$a3: Polycystic Ovary Syndrome: From Contraception to Hormone Replacement Therapy3.1 Introduction; 3.2 Endocrine Profile of PCOS; 3.3 PCOS, Brain and Abnormal Steroid Milieu; 3.4 Estrogen-Progestin Preparations and PCOS; References; 4: Management of Adolescent Hyperandrogenism; 4.1 Introduction; 4.2 Definition; 4.3 Causes of Hyperandrogenism in Adolescent Girls; 4.3.1 PCOS During Puberty; 4.3.2 Non-classical CAH; 4.3.3 Idiopathic Hirsutism; 4.3.4 Obesity; 4.4 Patient Evaluation; Conclusions; References; 5: Prevention of Adolescent Pregnancies; 5.1 Introduction; 5.2 Oral Contraceptives
000724858 5058_ $$a5.3 The Condom5.4 Emergency Contraception; 5.5 Long-Acting Reversible Contraceptives; 5.5.1 The Injectable Contraception; 5.5.2 The Levonorgestrel IUDs; 5.5.3 The Implants; 5.5.4 The Patch; 5.5.5 The Vaginal Ring; Conclusions; References; 6: Transsexualism: Endocrine Aspects; 6.1 Definition; 6.2 Etiology; 6.3 Incidence; 6.4 Diagnosis; 6.5 Therapy; 6.5.1 Male to Female Therapy; 6.5.2 Therapy for FM Transsexuals; 6.5.3 Possible Unwanted Effects of Therapy; Conclusion; References; Part II: Hormonal Contraception; 7: How to Choose the Right Contraceptive Method for the Right Woman
000724858 5058_ $$a7.1 Introduction7.2 The Contraceptive Triangle; 7.2.1 Method Variables; 7.2.2 Patient Variables; 7.2.3 Situation Variables; 7.3 Contraceptive Counseling and Care as an Interactive, Structured Process; 7.3.1 Step 1: Assess the Woman's Expectations and Preferences (Respect of Autonomy); 7.3.2 Step 2: Assess the Woman's Biopsychosocial Profile and Life Situation (Objective Patient and Situation Variables); 7.3.2.1 Biomedical Dimension; 7.3.2.2 Psychological Dimension; 7.3.2.3 Social Dimension
000724858 5058_ $$a7.3.3 Step 3: Educate Women About Methods with Understandable Risk/Benefit Information Based on EBM Results (Method Variables) (Beneficence)7.3.3.1 How Effective is Method x, y, and z to Prevent an Unwanted Pregnancy?; 7.3.3.2 How Much is the Effectiveness Dependent on Proper Use?; 7.3.3.3 What are the Health Risks of the Method?; 7.3.3.4 What are the Factors that Influence the Health Risks (Increase or Decrease)?; 7.3.3.5 What are the Possible Noncontraceptive Health Benefits of the Method?
000724858 506__ $$aAccess limited to authorized users.
000724858 520__ $$aThis volume offers an up-to-date overview on the major areas of gynecological endocrinology, presenting the latest advances in adolescent gynecological endocrinology, assisted reproduction, menstrual-related disorders, sexuality and transsexualism, polycystic ovary syndrome, myometrial pathology and adenomyosis, obesity and metabolic syndrome, hormonal contraception, premature ovarian failure and menopause. In each chapter the recent advances deriving from basic science and clinical investigations are related to the practical management of the condition under consideration, taking into accoun.
000724858 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed December 31, 2014).
000724858 650_0 $$aEndocrine gynecology.
000724858 7001_ $$aFauser, B. C. J. M.$$q(Bart C. J. M.),$$eeditor.
000724858 7001_ $$aGenazzani, Andrea R.,$$eeditor.
000724858 77608 $$iPrint version:$$aFauser, Bart C.J.M.$$tFrontiers in Gynecological Endocrinology : Volume 2: From Basic Science to Clinical Application$$dCham : Springer International Publishing,c2014$$z9783319096612
000724858 830_0 $$aISGE series.
000724858 852__ $$bebk
000724858 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-09662-9$$zOnline Access$$91397441.1
000724858 909CO $$ooai:library.usi.edu:724858$$pGLOBAL_SET
000724858 980__ $$aEBOOK
000724858 980__ $$aBIB
000724858 982__ $$aEbook
000724858 983__ $$aOnline
000724858 994__ $$a92$$bISE